Found: 397
Select item for more details and to access through your institution.
Optimization of canine CD20 chimeric antigen receptor T cell manufacturing and in vitro cytotoxic activity against B‐cell lymphoma.
- Published in:
- Veterinary & Comparative Oncology, 2020, v. 18, n. 4, p. 739, doi. 10.1111/vco.12602
- By:
- Publication type:
- Article
Phase 2 multicentre study of single‐agent ofatumumab in previously untreated follicular lymphoma: CALGB 50901 (Alliance).
- Published in:
- Angewandte Chemie, 2019, v. 131, n. 15, p. 53, doi. 10.1111/bjh.15768
- By:
- Publication type:
- Article
Structurally Defined αMHC-II Nanobody-Drug Conjugates: A Therapeutic and Imaging System for B-Cell Lymphoma.
- Published in:
- Angewandte Chemie, 2016, v. 128, n. 7, p. 2462, doi. 10.1002/ange.201509432
- By:
- Publication type:
- Article
Evaluation of the Effects of R-CHOP Chemotherapy on Brain Glucose Metabolism in Patients with Diffuse Large B Cell Lymphoma: A Baseline, Interim, and End-of-Treatment PET/CT Study.
- Published in:
- Tomography: A Journal for Imaging Research, 2022, v. 8, n. 5, p. 2565, doi. 10.3390/tomography8050214
- By:
- Publication type:
- Article
Antibodies: Kupffer cells mediate B cell depletion.
- Published in:
- Nature Reviews Immunology, 2013, v. 13, n. 12, p. 849, doi. 10.1038/nri3579
- By:
- Publication type:
- Article
Iatrogenic immunodeficiency-associated latent Epstein-Barr virus-related lymphomatoid granulomatosis initially presenting as unusual gynecological manifestations in a case of rheumatoid arthritis - a case report and review.
- Published in:
- Modern Rheumatology Case Reports, 2019, v. 3, n. 1, p. 5, doi. 10.1080/24725625.2018.1520418
- By:
- Publication type:
- Article
P5‐62: Evaluation of lung cell populations in severe COVID‐19 pneumonia.
- Published in:
- Respirology, 2021, v. 26, p. 181, doi. 10.1111/resp.14150_269
- Publication type:
- Article
Physiological Fitness and the Pathophysiology of Chronic Lymphocytic Leukemia (CLL).
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 5, p. 1165, doi. 10.3390/cells10051165
- By:
- Publication type:
- Article
Ocrelizumab Depletes CD20+ T Cells in Multiple Sclerosis Patients.
- Published in:
- Cells (2073-4409), 2019, v. 8, n. 1, p. 12, doi. 10.3390/cells8010012
- By:
- Publication type:
- Article
State‐of‐the‐art review of human autoimmune blistering diseases (AIBD).
- Published in:
- Veterinary Dermatology, 2021, v. 32, n. 6, p. 524, doi. 10.1111/vde.13008
- By:
- Publication type:
- Article
Prevalence of CD20<sup>+</sup> cutaneous epitheliotropic T‐cell lymphoma in dogs: a retrospective analysis of 24 cases (2011–2018) in the USA.
- Published in:
- Veterinary Dermatology, 2019, v. 30, n. 1, p. 51, doi. 10.1111/vde.12703
- By:
- Publication type:
- Article
A retrospective study comparing histopathological and immunopathological features of nasal planum dermatitis in 20 dogs with discoid lupus erythematosus or leishmaniosis.
- Published in:
- Veterinary Dermatology, 2017, v. 28, n. 2, p. 200, doi. 10.1111/vde.12419
- By:
- Publication type:
- Article
Distribution and efficacy of ofatumumab and ocrelizumab in humanized CD20 mice following subcutaneous or intravenous administration.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.814064
- By:
- Publication type:
- Article
Intravascular Large B-Cell Lymphoma Mimicking Temporal Arteritis.
- Published in:
- Case Reports in Rheumatology, 2018, p. 1, doi. 10.1155/2018/5364985
- By:
- Publication type:
- Article
Immunohistochemical Evaluation of CD3, CD4, CD8, and CD20 in Decidual and Trophoblastic Tissue Specimens of Patients with Recurrent Pregnancy Loss.
- Published in:
- Clinics & Practice, 2022, v. 12, n. 2, p. 177, doi. 10.3390/clinpract12020022
- By:
- Publication type:
- Article
Dengue fever in a multiple sclerosis patient taking Ocrelizumab.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 13, p. 2116, doi. 10.1177/13524585211030214
- By:
- Publication type:
- Article
A phase 2 multicenter study of ublituximab, a novel glycoengineered anti-CD20 monoclonal antibody, in patients with relapsing forms of multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 3, p. 420, doi. 10.1177/1352458520918375
- By:
- Publication type:
- Article
Free Communications 4 - Treatment.
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, p. 84, doi. 10.1177/1352458518798579
- Publication type:
- Article
Anti-CD20 Antibody is Effective in the Patient with Refractory Amegakaryocytic Thrombocytopenia, 25 Months Follow up.
- Published in:
- 2014
- By:
- Publication type:
- Case Study
Evaluation of pediatric rheumatologists' approach to rituximab use: a questionnaire study.
- Published in:
- European Journal of Pediatrics, 2024, v. 183, n. 9, p. 3959, doi. 10.1007/s00431-024-05654-9
- By:
- Publication type:
- Article
CAR T-cell Therapy of Hematologic Malignancies: An Update in Targeted Antigens.
- Published in:
- Iranian Journal of Pediatric Hematology & Oncology, 2023, v. 13, n. 2, p. 144, doi. 10.18502/ijpho.v13i2.12343
- By:
- Publication type:
- Article
Spatiotemporal Dynamics of Insulitis in Human Type 1 Diabetes.
- Published in:
- Frontiers in Physiology, 2016, v. 7, p. 1, doi. 10.3389/fphys.2016.00633
- By:
- Publication type:
- Article
Rituximab Use and Hypogammaglobulinemia.
- Published in:
- American Journal of Case Reports, 2020, v. 21, p. 1, doi. 10.12659/AJCR.920681
- By:
- Publication type:
- Article
Effects of Rituximab on JAK-STAT and NF-κB signaling pathways in acute lymphoblastic leukemia and chronic lymphocytic leukemia.
- Published in:
- Turkish Journal of Biochemistry / Turk Biyokimya Dergisi, 2019, v. 44, n. 4, p. 499, doi. 10.1515/tjb-2018-0321
- By:
- Publication type:
- Article
Identification of relevant drugable targets in diffuse large B-cell lymphoma using a genome-wide unbiased CD20 guilt-by association approach.
- Published in:
- PLoS ONE, 2018, v. 13, n. 2, p. 1, doi. 10.1371/journal.pone.0193098
- By:
- Publication type:
- Article
The B cell death function of obinutuzumab-HDEL produced in plant (Nicotiana benthamiana L.) is equivalent to obinutuzumab produced in CHO cells.
- Published in:
- PLoS ONE, 2018, v. 13, n. 1, p. 1, doi. 10.1371/journal.pone.0191075
- By:
- Publication type:
- Article
LIJEČENJE MULTIPLE SKLEROZE LIJEKOM OKRELIZUMAB - RETROSPEKTIVNA 1,5-GODIŠNJA ANALIZA U KLINICI ZA NEUROLOGIJU KLINIČKOG BOLNIČKOG CENTRA SESTRE MILOSRDNICE U ZAGREBU.
- Published in:
- Acta Medica Croatica, 2020, v. 74, n. 3, p. 265
- By:
- Publication type:
- Article
Focus on improved patient management.
- Published in:
- 2019
- By:
- Publication type:
- editorial
In Silico Analysis for Determination and Validation of Human CD20 Antigen 3D Structure.
- Published in:
- International Journal of Peptide Research & Therapeutics, 2019, v. 25, n. 1, p. 123, doi. 10.1007/s10989-017-9654-9
- By:
- Publication type:
- Article
Anti-CD20 single chain variable antibody fragment-apolipoprotein A-I chimera containing nanodisks promote targeted bioactive agent delivery to CD20-positive lymphomas.
- Published in:
- Biochemistry & Cell Biology, 2015, v. 93, n. 4, p. 343, doi. 10.1139/bcb-2015-0009
- By:
- Publication type:
- Article
Structural analysis of the lipopolysaccharide O-antigen from Fusobacterium nucleatum strain CC 7/3 JVN3 C1 and development of a mouse monoclonal antibody specific to the O-antigen.
- Published in:
- Canadian Journal of Microbiology, 2020, v. 66, n. 9, p. 529, doi. 10.1139/cjm-2020-0117
- By:
- Publication type:
- Article
Genetic Background Amplifies the Effect of Immunodeficiency in Antibiotic Efficacy Against Borrelia burgdorferi.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Epstein-Barr Virus–Positive CD20- and CD45-Negative Diffuse Large B-Cell Lymphoma: A Diagnostic Challenge.
- Published in:
- 2019
- By:
- Publication type:
- Case Study
Tumor infiltrating lymphocytes profile and response in neoadjuvant chemotherapy-treated triple-negative breast carcinoma patients.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Florid reactive lymphoid hyperplasia (lymphoma-like lesion) of cervix: A diagnostically challenging case and a brief review of literature.
- Published in:
- 2015
- By:
- Publication type:
- case study
CD20 negative primary diffuse large B cell lymphoma of breast: Role of Pax-5.
- Published in:
- 2015
- By:
- Publication type:
- case study
Primary non-Hodgkin lymphoma of the vulva in an immunocompetent patient.
- Published in:
- 2015
- By:
- Publication type:
- case study
Intraorbital injection of Rituximab in idiopathic orbital inflammatory syndrome: case reports.
- Published in:
- Rheumatology International, 2015, v. 35, n. 1, p. 183, doi. 10.1007/s00296-014-3054-7
- By:
- Publication type:
- Article
Rituximab treatment for Sjogren syndrome-associated non-Hodgkin's lymphoma: case series.
- Published in:
- Rheumatology International, 2012, v. 32, n. 10, p. 3281, doi. 10.1007/s00296-011-2036-2
- By:
- Publication type:
- Article
Selection and Characterization of Single-Stranded DNA Aptamers Binding Human B-Cell Surface Protein CD20 by Cell-SELEX.
- Published in:
- Molecules, 2018, v. 23, n. 4, p. 715, doi. 10.3390/molecules23040715
- By:
- Publication type:
- Article
Anti-Lymphoma Efficacy Comparison of Anti-CD20 Monoclonal Antibody-Targeted and Non-Targeted Star-Shaped Polymer-Prodrug Conjugates.
- Published in:
- Molecules, 2015, v. 20, n. 11, p. 19849, doi. 10.3390/molecules201119664
- By:
- Publication type:
- Article
Sequence variation of the Epstein-Barr virus nuclear antigen 1 (EBNA1) gene in chronic lymphocytic leukemia and healthy volunteer subjects.
- Published in:
- Archives of Virology, 2024, v. 169, n. 1, p. 1, doi. 10.1007/s00705-023-05933-0
- By:
- Publication type:
- Article
Blood Microvesicles during Chronic Lymphoproliferative Diseases.
- Published in:
- Bulletin of Experimental Biology & Medicine, 2013, v. 156, n. 1, p. 94, doi. 10.1007/s10517-013-2286-y
- By:
- Publication type:
- Article
T-Cell Immunotherapy: Looking Forward.
- Published in:
- Molecular Therapy, 2014, v. 22, n. 9, p. 1564, doi. 10.1038/mt.2014.148
- By:
- Publication type:
- Article
Development of a Bispecific Nanobody Targeting CD20 on B-Cell Lymphoma Cells and CD3 on T Cells.
- Published in:
- Vaccines, 2022, v. 10, n. 8, p. 1335, doi. 10.3390/vaccines10081335
- By:
- Publication type:
- Article
Potential for a Plant-Made SARS-CoV-2 Neutralizing Monoclonal Antibody as a Synergetic Cocktail Component.
- Published in:
- Vaccines, 2022, v. 10, n. 5, p. 772, doi. 10.3390/vaccines10050772
- By:
- Publication type:
- Article
Humoral Immune Response after the Third SARS-CoV-2 mRNA Vaccination in CD20 Depleted People with Multiple Sclerosis.
- Published in:
- Vaccines, 2021, v. 9, n. 12, p. 1470, doi. 10.3390/vaccines9121470
- By:
- Publication type:
- Article
The role of the immune system in idiopathic nephrotic syndrome.
- Published in:
- Molecular & Cellular Pediatrics, 2021, v. 8, n. 1, p. 1, doi. 10.1186/s40348-021-00128-6
- By:
- Publication type:
- Article
Detailed bladder cancer immunoprofiling reveals new clues for immunotherapeutic strategies.
- Published in:
- Clinical & Translational Immunology, 2022, v. 11, n. 9, p. 1, doi. 10.1002/cti2.1402
- By:
- Publication type:
- Article
Allogeneic CD20‐targeted γδ T cells exhibit innate and adaptive antitumor activities in preclinical B‐cell lymphoma models.
- Published in:
- Clinical & Translational Immunology, 2022, v. 11, n. 2, p. 1, doi. 10.1002/cti2.1373
- By:
- Publication type:
- Article